首页 > 最新文献

Acta medica Indonesiana最新文献

英文 中文
Unusual Presentation of Unilateral Choroidal Melanoma with Bilateral Vasculitis in Young Individual: A Case Report and Review of Literature. 年轻患者单侧脉络膜黑色素瘤伴双侧血管炎的罕见表现:病例报告与文献综述。
IF 1.4 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-01-01
Saleh S Algamdi, Dhoha M Alhamad

Ocular melanoma stands as the predominant primary intraocular malignancy, albeit infrequently exhibiting ipsilateral inflammatory manifestations. In this article, we present an exceptional case involving a middle-aged male who presented with unilateral ocular choroidal melanoma alongside bilateral retinal vasculitis. The patient initially received temporary steroid treatment, followed by brachytherapy, which contributed to the resolution of vasculitis symptoms. The study aims to document the atypical occurrence of bilateral retinal vasculitis, which could potentially masquerade as melanoma, emphasizing the need for heightened vigilance and further investigations when encountering choroidal masses in its presence. Future research endeavors are warranted to better understand the incidence of such occurrences in this context.

眼部黑色素瘤是眼内最主要的原发性恶性肿瘤,但很少出现同侧炎症表现。本文介绍了一例特殊病例,患者是一名中年男性,单侧眼脉络膜黑色素瘤,同时伴有双侧视网膜血管炎。患者最初接受了临时类固醇治疗,随后接受了近距离放射治疗,这有助于血管炎症状的缓解。本研究旨在记录双侧视网膜血管炎的非典型发生,它有可能伪装成黑色素瘤,强调在遇到脉络膜肿块时需要提高警惕并进行进一步检查。为了更好地了解这种情况的发生率,未来的研究工作是有必要的。
{"title":"Unusual Presentation of Unilateral Choroidal Melanoma with Bilateral Vasculitis in Young Individual: A Case Report and Review of Literature.","authors":"Saleh S Algamdi, Dhoha M Alhamad","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Ocular melanoma stands as the predominant primary intraocular malignancy, albeit infrequently exhibiting ipsilateral inflammatory manifestations. In this article, we present an exceptional case involving a middle-aged male who presented with unilateral ocular choroidal melanoma alongside bilateral retinal vasculitis. The patient initially received temporary steroid treatment, followed by brachytherapy, which contributed to the resolution of vasculitis symptoms. The study aims to document the atypical occurrence of bilateral retinal vasculitis, which could potentially masquerade as melanoma, emphasizing the need for heightened vigilance and further investigations when encountering choroidal masses in its presence. Future research endeavors are warranted to better understand the incidence of such occurrences in this context.</p>","PeriodicalId":6889,"journal":{"name":"Acta medica Indonesiana","volume":"56 1","pages":"102-106"},"PeriodicalIF":1.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140334260","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Challenges in Diagnosis and Treatment of Male Hypogonadism. 男性性腺功能减退症诊断和治疗的挑战。
IF 1.4 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-01-01
Dyah Purnamasari

Hypogonadism is a condition characterized by diminished or absent production of sex hormones by the testicles in men and the ovaries in women. Hypogonadism is classified into primary and secondary hypogonadism. Each type of hypogonadism can be caused by congenital and acquired factors. There are many factors that contribute to the occurrence of hypogonadism, including genetic and developmental disorders, infection, kidney disease, liver disease, autoimmune disorders, chemotherapy, radiation, surgery, and trauma. This represents the considerable challenge in diagnosing hypogonadism.The goals of treatment include restore sexual functionality and well-being, initiating and sustaining virilization, osteoporosis prevention, normalize growth hormone levels in elderly men if possible, and restoring fertility in instances of hypogonadotropic hypogonadism. The main approach to treating hypogonadism is hormone replacement therapy. Male with prostate cancer, breast cancer, and untreated prolactinoma are contraindicated for hormone replacement therapy. When selecting a type of testosterone therapy for male with hypogonadism, several factors need to be considered, such as the diversity of treatment response and the  type of testosterone formulation. The duration of therapy depends on individual response, therapeutic goals, signs and symptoms, and hormonal levels. The response to testosterone therapy is evaluated based on symptoms and signs as well as improvements in hormone profiles in the blood. Endocrine Society Clinical Practice Guideline recommend therapeutic goals based on the alleviation of symptoms and signs, as well as reaching testosterone levels between 400 - 700 ng/dL (one week after administering testosterone enanthate or cypionate) and maintaining baseline hematocrit.Hormone therapy is the primary modality in the management of hypogonadism. The variety of signs and symptoms makes early diagnosis of this condition challenging. Moreover, administering hypogonadism therapy involves numerous considerations influenced by various patient factors and the potential for adverse effects. This poses a challenge for physicians to provide targeted hypogonadism therapy with minimal complications.

性腺功能减退症是一种以男性睾丸和女性卵巢分泌的性激素减少或缺乏为特征的疾病。性腺功能减退症分为原发性和继发性性腺功能减退症。每种性腺功能减退症都可能由先天和后天因素引起。导致性腺功能减退症发生的因素有很多,包括遗传和发育障碍、感染、肾脏疾病、肝脏疾病、自身免疫性疾病、化疗、放疗、手术和创伤。治疗的目标包括恢复性功能和性健康、启动和维持男性化、预防骨质疏松症、尽可能使老年男性的生长激素水平恢复正常,以及在性腺功能减退的情况下恢复生育能力。治疗性腺功能减退症的主要方法是激素替代疗法。患有前列腺癌、乳腺癌和未经治疗的催乳素瘤的男性禁用激素替代疗法。在为性腺功能减退症男性患者选择睾酮疗法类型时,需要考虑几个因素,如治疗反应的多样性和睾酮配方的类型。治疗持续时间取决于个体反应、治疗目标、体征和症状以及激素水平。根据症状和体征以及血液中激素水平的改善情况来评估对睾酮治疗的反应。内分泌学会临床实践指南建议,治疗目标应基于症状和体征的缓解,以及睾酮水平达到 400 - 700 ng/dL(施用庚酸睾酮或环丙酸睾酮一周后)和维持基线血细胞比容。激素治疗是治疗性腺功能减退症的主要方法。由于症状和体征多种多样,因此这种疾病的早期诊断具有挑战性。此外,性腺功能减退症的治疗需要考虑患者的各种因素和潜在的不良反应。这就给医生带来了挑战,如何在提供有针对性的性腺功能减退症治疗的同时将并发症降至最低。
{"title":"Challenges in Diagnosis and Treatment of Male Hypogonadism.","authors":"Dyah Purnamasari","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Hypogonadism is a condition characterized by diminished or absent production of sex hormones by the testicles in men and the ovaries in women. Hypogonadism is classified into primary and secondary hypogonadism. Each type of hypogonadism can be caused by congenital and acquired factors. There are many factors that contribute to the occurrence of hypogonadism, including genetic and developmental disorders, infection, kidney disease, liver disease, autoimmune disorders, chemotherapy, radiation, surgery, and trauma. This represents the considerable challenge in diagnosing hypogonadism.The goals of treatment include restore sexual functionality and well-being, initiating and sustaining virilization, osteoporosis prevention, normalize growth hormone levels in elderly men if possible, and restoring fertility in instances of hypogonadotropic hypogonadism. The main approach to treating hypogonadism is hormone replacement therapy. Male with prostate cancer, breast cancer, and untreated prolactinoma are contraindicated for hormone replacement therapy. When selecting a type of testosterone therapy for male with hypogonadism, several factors need to be considered, such as the diversity of treatment response and the  type of testosterone formulation. The duration of therapy depends on individual response, therapeutic goals, signs and symptoms, and hormonal levels. The response to testosterone therapy is evaluated based on symptoms and signs as well as improvements in hormone profiles in the blood. Endocrine Society Clinical Practice Guideline recommend therapeutic goals based on the alleviation of symptoms and signs, as well as reaching testosterone levels between 400 - 700 ng/dL (one week after administering testosterone enanthate or cypionate) and maintaining baseline hematocrit.Hormone therapy is the primary modality in the management of hypogonadism. The variety of signs and symptoms makes early diagnosis of this condition challenging. Moreover, administering hypogonadism therapy involves numerous considerations influenced by various patient factors and the potential for adverse effects. This poses a challenge for physicians to provide targeted hypogonadism therapy with minimal complications.</p>","PeriodicalId":6889,"journal":{"name":"Acta medica Indonesiana","volume":"56 1","pages":"1-2"},"PeriodicalIF":1.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140334279","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endoscopic Dilatation with Ultrathin Endoscope Assisted Method for Esophageal and Pyloric Stricture related Corrosive Injury: 4 Years Case Series Study. 用超薄内窥镜辅助方法进行内窥镜扩张术治疗与腐蚀性损伤相关的食管和幽门狭窄:4年病例系列研究。
IF 1.4 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-01-01
Rusdiyana Ekawati, Nurike Setyari Mudjari, Arianti Arianti, Annisa Zahra Mufida, Budi Widodo, Titong Sugihartono, Herry Purbayu

Corrosive injuries (CI) become medical problems related complications include esophageal, pyloric stricture and squamous cell carcinoma, physical and quality of life. Endoscopic (ED) dilatation is primary therapy. The ultrathin endoscope-assisted method is potentially safe and useful in avoiding technical failure. Describe clinical outcomes of ED ED-related CI including successful, refractory, recurrent, and complications-related procedures. Case series study of esophageal and/or pyloric stricture patients after CI who underwent dilatation at Soetomo General Hospital (July 2018 - July 2022). One - biweekly ED using Through The Scope (TTS) balloon or Savary Bougie dilator. The target diameter is 14mm. Fifteen patients with stricture-related CI. Eleven patients underwent ED with a total of 73 procedures. Mean age 31,45 years, predominantly male patients (6), suicide attempt (7), acid agent (9), located at esophagus (3), pylorus (3), or both (5). Number of esophageal dilatation to achieve the target of 14 mm was 1-2 and 2-15 procedures for simple and complex stricture. Five esophageal strictures were successfully dilated but 2 patients were recurrent and 3 cases were refractory to ED. Pyloric dilatation resulted in a lower success rate. Recurrent and refractory cases were 5 and 3 patients respectively. ED with ultrathin endoscope method is useful for traversing guidewire during ED. Ongoing inflammation and fibrosis were linked to recurrent and refractory stricture.

腐蚀性损伤(CI)成为医疗问题,相关并发症包括食管、幽门狭窄和鳞状细胞癌、身体和生活质量。内窥镜(ED)扩张术是主要的治疗方法。超薄内窥镜辅助方法在避免技术失败方面具有潜在的安全性和实用性。描述与 ED 相关的 CI 的临床结果,包括成功、难治、复发以及与并发症相关的手术。对在 Soetomo 综合医院接受扩张术的 CI 后食管和/或幽门狭窄患者进行病例系列研究(2018 年 7 月 - 2022 年 7 月)。使用Through The Scope(TTS)球囊或Savary Bougie扩张器,每两周进行一次ED。目标直径为 14 毫米。15 名患者患有与狭窄相关的 CI。11 名患者接受了 ED,共进行了 73 次手术。平均年龄 31,45 岁,主要为男性患者(6 例),自杀未遂(7 例),酸制剂(9 例),位于食管(3 例)、幽门(3 例)或两者(5 例)。为达到 14 毫米的目标,简单和复杂狭窄的食管扩张次数分别为 1-2 次和 2-15 次。有 5 例食管狭窄患者成功扩张,但其中 2 例复发,3 例对 ED 难以奏效。幽门扩张术的成功率较低。复发和难治病例分别为 5 例和 3 例。使用超薄内窥镜方法进行 ED 有助于在 ED 过程中穿越导丝。持续的炎症和纤维化与复发性和难治性狭窄有关。
{"title":"Endoscopic Dilatation with Ultrathin Endoscope Assisted Method for Esophageal and Pyloric Stricture related Corrosive Injury: 4 Years Case Series Study.","authors":"Rusdiyana Ekawati, Nurike Setyari Mudjari, Arianti Arianti, Annisa Zahra Mufida, Budi Widodo, Titong Sugihartono, Herry Purbayu","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Corrosive injuries (CI) become medical problems related complications include esophageal, pyloric stricture and squamous cell carcinoma, physical and quality of life. Endoscopic (ED) dilatation is primary therapy. The ultrathin endoscope-assisted method is potentially safe and useful in avoiding technical failure. Describe clinical outcomes of ED ED-related CI including successful, refractory, recurrent, and complications-related procedures. Case series study of esophageal and/or pyloric stricture patients after CI who underwent dilatation at Soetomo General Hospital (July 2018 - July 2022). One - biweekly ED using Through The Scope (TTS) balloon or Savary Bougie dilator. The target diameter is 14mm. Fifteen patients with stricture-related CI. Eleven patients underwent ED with a total of 73 procedures. Mean age 31,45 years, predominantly male patients (6), suicide attempt (7), acid agent (9), located at esophagus (3), pylorus (3), or both (5). Number of esophageal dilatation to achieve the target of 14 mm was 1-2 and 2-15 procedures for simple and complex stricture. Five esophageal strictures were successfully dilated but 2 patients were recurrent and 3 cases were refractory to ED. Pyloric dilatation resulted in a lower success rate. Recurrent and refractory cases were 5 and 3 patients respectively. ED with ultrathin endoscope method is useful for traversing guidewire during ED. Ongoing inflammation and fibrosis were linked to recurrent and refractory stricture.</p>","PeriodicalId":6889,"journal":{"name":"Acta medica Indonesiana","volume":"56 1","pages":"84-92"},"PeriodicalIF":1.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140334282","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Proportion of Hypogonadism in Transfusion-Dependent Thalassemia Patients and Its Contributing Factors. 输血依赖型地中海贫血患者性腺功能低下的比例及其诱因
IF 1.4 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-01-01
Dian Anindita Lubis, Imam Subekti, Em Yunir, Cosphiadi Irawan, Andon Hestiantoro, Silvia Werdhy Lestari, Aria Kekalih, Merci Monica Br Pasaribu, Santi Syafril

Background: Beta thalassemia is a lifelong disease involving malformed red blood cells (RBC). One of the disease's complications is hypogonadism, in which adults tend to exhibit regression in sexual characteristics, experience sexual dysfunction, and therefore have a lower quality of life. Around 3-10% of the Indonesian population carries the beta-thalassemia gene. This study aimed to see the proportions of hypogonadism in transfusion-dependent thalassemia patients and its contributing factors.

Methods: This is a cross-sectional study involving 60 male patients admitted to three Indonesian general hospitals from July 2022 to July 2023. All patients were diagnosed with beta-thalassemia via chromatography hemoglobin analysis. We performed a single-time physical examination and laboratory examinations to determine FSH, LH, and free testosterone levels. The correlation between Hb and sexual hormone levels was analyzed using Spearman's rank correlation coefficient. ROC curve analysis was conducted afterward. All statistical analysis was done in SPSS version 29.

Results: 31 out of 60 thalassemia patients had hypogonadism. Pre-transfusion Hb count was found to be linearly correlated with FSH (r = 0.388, p = 0.049), LH (r = 0.338, p = 0.008), and free testosterone (r = 0.255, p = 0.049). ROC analysis indicated that pre-transfusion Hb was viable as a predictor for hypogonadism (AUC = 0.655, 65.5% sensitivity, 67.7% specificity).

Conclusion: We confirmed the role of pre-transfusion Hb count as a potential predictor for hypogonadism due to the tissue hypoxia mechanism and transfusion-related iron overload in TDT patients. Decreased Hb is linearly correlated with FSH, LH, and testosterone levels. Decreased Hb also downregulates these factors.

背景:地中海贫血是一种涉及畸形红细胞(RBC)的终身性疾病。该病的并发症之一是性腺功能减退,成年人往往表现出性征退化、性功能障碍,因此生活质量较低。印尼人口中约有 3-10%携带β-地中海贫血基因。本研究旨在了解输血依赖型地中海贫血患者性腺功能低下的比例及其诱因:这是一项横断面研究,涉及 2022 年 7 月至 2023 年 7 月期间印度尼西亚三家综合医院收治的 60 名男性患者。所有患者均通过色谱血红蛋白分析确诊为β地中海贫血。我们进行了一次性体检和实验室检查,以确定 FSH、LH 和游离睾酮水平。使用斯皮尔曼等级相关系数分析了 Hb 与性激素水平之间的相关性。随后进行了 ROC 曲线分析。所有统计分析均在 SPSS 29 版本中完成:在 60 名地中海贫血患者中,31 人患有性腺功能减退症。输血前 Hb 计数与 FSH(r = 0.388,p = 0.049)、LH(r = 0.338,p = 0.008)和游离睾酮(r = 0.255,p = 0.049)呈线性相关。ROC分析表明,输血前Hb作为性腺功能减退症的预测因子是可行的(AUC = 0.655,敏感性65.5%,特异性67.7%):我们证实了输血前白蛋白计数作为性腺功能减退症潜在预测因子的作用,这是由于组织缺氧机制和输血相关的铁超载导致了TDT患者的性腺功能减退症。Hb 减少与 FSH、LH 和睾酮水平呈线性相关。Hb 降低也会下调这些因子。
{"title":"Proportion of Hypogonadism in Transfusion-Dependent Thalassemia Patients and Its Contributing Factors.","authors":"Dian Anindita Lubis, Imam Subekti, Em Yunir, Cosphiadi Irawan, Andon Hestiantoro, Silvia Werdhy Lestari, Aria Kekalih, Merci Monica Br Pasaribu, Santi Syafril","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Beta thalassemia is a lifelong disease involving malformed red blood cells (RBC). One of the disease's complications is hypogonadism, in which adults tend to exhibit regression in sexual characteristics, experience sexual dysfunction, and therefore have a lower quality of life. Around 3-10% of the Indonesian population carries the beta-thalassemia gene. This study aimed to see the proportions of hypogonadism in transfusion-dependent thalassemia patients and its contributing factors.</p><p><strong>Methods: </strong>This is a cross-sectional study involving 60 male patients admitted to three Indonesian general hospitals from July 2022 to July 2023. All patients were diagnosed with beta-thalassemia via chromatography hemoglobin analysis. We performed a single-time physical examination and laboratory examinations to determine FSH, LH, and free testosterone levels. The correlation between Hb and sexual hormone levels was analyzed using Spearman's rank correlation coefficient. ROC curve analysis was conducted afterward. All statistical analysis was done in SPSS version 29.</p><p><strong>Results: </strong>31 out of 60 thalassemia patients had hypogonadism. Pre-transfusion Hb count was found to be linearly correlated with FSH (r = 0.388, p = 0.049), LH (r = 0.338, p = 0.008), and free testosterone (r = 0.255, p = 0.049). ROC analysis indicated that pre-transfusion Hb was viable as a predictor for hypogonadism (AUC = 0.655, 65.5% sensitivity, 67.7% specificity).</p><p><strong>Conclusion: </strong>We confirmed the role of pre-transfusion Hb count as a potential predictor for hypogonadism due to the tissue hypoxia mechanism and transfusion-related iron overload in TDT patients. Decreased Hb is linearly correlated with FSH, LH, and testosterone levels. Decreased Hb also downregulates these factors.</p>","PeriodicalId":6889,"journal":{"name":"Acta medica Indonesiana","volume":"56 1","pages":"13-19"},"PeriodicalIF":1.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140334255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Significant Inverse Correlation of Serum Levels of Osteoprotegerin (OPG) and Transferrin Saturation in Thalassemia Dependent Transfusion (TDT) Patients. 地中海贫血依赖性输血(TDT)患者血清中的骨保护蛋白(OPG)水平与转铁蛋白饱和度呈显著的反向相关性。
IF 1.4 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-01-01
Indra Wijaya, M Lucky Nurdiansyah Prameswara, Dimmy Prasetya, Laniyati Hamijoyo, Bachti Alisjahbana, Andri Reza Rahmadi

Background: Osteoporosis is a major problem in transfusion-dependent thalassemia patients (TDT) patients. Osteoprotegerin (OPG) is one of several bone markers that are closely associated with osteoporosis in TDT patients. OPG is a glycoprotein that functions as a feedback receptor for the Receptor Activator of Nuclear Factor kappa B Ligand (RANKL), which is an alpha tumor necrosis factor receptor. One of the causes of decreased bone mass density is iron toxicity, which can be identified by showing elevated transferrin saturation. Bone mass dual X-ray absorptiometry (DEXA) is a gold standard for the diagnosis of osteoporosis, these procedures are not commonly available in Indonesia. This study was conducted to analyze the correlation between serum levels of OPG and transferrin saturation in TDT patients.

Methods: A correlational study with a cross-sectional approach analyzed data from TDT patients at Hemato-Oncology Medic Outpatient Clinic, Hasan Sadikin General Hospital, Bandung, Indonesia. Primary data were obtained through blood sampling and anthropometry measurement while secondary data were obtained from the patient's medical records. OPG and transferrin saturation levels were assessed using the ELISA method. Research data were analyzed using the rank Spearman correlation test.

Results: Data were collected from 51 research subjects (30 women dan 21 men). The median OPG level was 380 (170-1230) pg/mL and the median transferrin saturation level was 89.4 (66.7 - 96.2)%. Analysis of correlation showed a significant correlation between and transferrin saturation level with a coefficient value of r -0.539 and p-value <0.001.

Conclusion: There was a significant inverse correlation between OPG with transferrin saturation in TDT patients.

背景:骨质疏松症是输血依赖型地中海贫血患者(TDT)的主要问题:骨质疏松症是输血依赖型地中海贫血患者(TDT)的一个主要问题。骨蛋白激酶(OPG)是与地中海贫血患者骨质疏松症密切相关的几种骨标记物之一。OPG 是一种糖蛋白,可作为核因子卡巴 B 配体受体激活剂(RANKL)的反馈受体,而 RANKL 是一种α 肿瘤坏死因子受体。铁中毒是导致骨质密度下降的原因之一,可通过显示转铁蛋白饱和度升高来确定。骨质双 X 射线吸收测定(DEXA)是诊断骨质疏松症的金标准,但在印尼这些程序并不常见。本研究旨在分析 TDT 患者血清中 OPG 水平与转铁蛋白饱和度之间的相关性:方法:这是一项横断面相关性研究,分析了印度尼西亚万隆哈桑-萨迪金综合医院血液肿瘤内科门诊的 TDT 患者的数据。主要数据通过抽血和人体测量获得,次要数据则来自患者的医疗记录。采用 ELISA 方法评估 OPG 和转铁蛋白饱和度水平。研究数据采用等级斯皮尔曼相关性检验进行分析:共收集了 51 名研究对象(30 名女性和 21 名男性)的数据。OPG水平中位数为380 (170-1230) pg/mL,转铁蛋白饱和度中位数为89.4 (66.7 - 96.2)%。相关性分析表明,OPG 与转铁蛋白饱和度之间存在显著相关性,相关系数为 r -0.539,P 值为 结论:在 TDT 患者中,OPG 与转铁蛋白饱和度之间存在明显的反相关性。
{"title":"Significant Inverse Correlation of Serum Levels of Osteoprotegerin (OPG) and Transferrin Saturation in Thalassemia Dependent Transfusion (TDT) Patients.","authors":"Indra Wijaya, M Lucky Nurdiansyah Prameswara, Dimmy Prasetya, Laniyati Hamijoyo, Bachti Alisjahbana, Andri Reza Rahmadi","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Osteoporosis is a major problem in transfusion-dependent thalassemia patients (TDT) patients. Osteoprotegerin (OPG) is one of several bone markers that are closely associated with osteoporosis in TDT patients. OPG is a glycoprotein that functions as a feedback receptor for the Receptor Activator of Nuclear Factor kappa B Ligand (RANKL), which is an alpha tumor necrosis factor receptor. One of the causes of decreased bone mass density is iron toxicity, which can be identified by showing elevated transferrin saturation. Bone mass dual X-ray absorptiometry (DEXA) is a gold standard for the diagnosis of osteoporosis, these procedures are not commonly available in Indonesia. This study was conducted to analyze the correlation between serum levels of OPG and transferrin saturation in TDT patients.</p><p><strong>Methods: </strong>A correlational study with a cross-sectional approach analyzed data from TDT patients at Hemato-Oncology Medic Outpatient Clinic, Hasan Sadikin General Hospital, Bandung, Indonesia. Primary data were obtained through blood sampling and anthropometry measurement while secondary data were obtained from the patient's medical records. OPG and transferrin saturation levels were assessed using the ELISA method. Research data were analyzed using the rank Spearman correlation test.</p><p><strong>Results: </strong>Data were collected from 51 research subjects (30 women dan 21 men). The median OPG level was 380 (170-1230) pg/mL and the median transferrin saturation level was 89.4 (66.7 - 96.2)%. Analysis of correlation showed a significant correlation between and transferrin saturation level with a coefficient value of r -0.539 and p-value <0.001.</p><p><strong>Conclusion: </strong>There was a significant inverse correlation between OPG with transferrin saturation in TDT patients.</p>","PeriodicalId":6889,"journal":{"name":"Acta medica Indonesiana","volume":"56 1","pages":"20-25"},"PeriodicalIF":1.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140334257","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Consensus Guidelines for Influenza Vaccination in Patients with Diabetes. 糖尿病患者接种流感疫苗的共识指南。
IF 1.4 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-01-01
Sukamto Koesnoe, Anshari Saifuddin Hasibuan, Ketut Suastika, Cissy Kartasasmita, Andi Makbul Aman, Ida Ayu Kshanti, Wismandari Wisnu, Samsuridjal Djauzi, Iris Rengganis, Alvina Widhani, Suzy Maria, Erwanto Budi Winulyo, Hindra Irawan, Heri Nugroho, Nanny Soetedjo, Sobagijo Adi, Hendra Zufry, Nabilla Gita

Influenza is a prevalent health issue encountered in daily practice. Patients with diabetes mellitus face a higher risk of infections, including influenza, owing to the compromised immune system associated with diabetes. This susceptibility arises from the potential of diabetes mellitus to weaken the immune system. Moreover, elevated blood glucose levels can create a conducive environment for the growth of bacteria and viruses. This consensus is formulated by a multidisciplinary team to serve as practical guidance for the administration of influenza vaccinations to patients with diabetes mellitus in daily practice.

流感是日常工作中普遍遇到的健康问题。糖尿病患者由于免疫系统受损,感染流感等疾病的风险较高。这种易感性源于糖尿病可能削弱免疫系统。此外,血糖水平升高会为细菌和病毒的生长创造有利环境。本共识由一个多学科团队制定,旨在为糖尿病患者在日常接种流感疫苗时提供实用指导。
{"title":"Consensus Guidelines for Influenza Vaccination in Patients with Diabetes.","authors":"Sukamto Koesnoe, Anshari Saifuddin Hasibuan, Ketut Suastika, Cissy Kartasasmita, Andi Makbul Aman, Ida Ayu Kshanti, Wismandari Wisnu, Samsuridjal Djauzi, Iris Rengganis, Alvina Widhani, Suzy Maria, Erwanto Budi Winulyo, Hindra Irawan, Heri Nugroho, Nanny Soetedjo, Sobagijo Adi, Hendra Zufry, Nabilla Gita","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Influenza is a prevalent health issue encountered in daily practice. Patients with diabetes mellitus face a higher risk of infections, including influenza, owing to the compromised immune system associated with diabetes. This susceptibility arises from the potential of diabetes mellitus to weaken the immune system. Moreover, elevated blood glucose levels can create a conducive environment for the growth of bacteria and viruses. This consensus is formulated by a multidisciplinary team to serve as practical guidance for the administration of influenza vaccinations to patients with diabetes mellitus in daily practice.</p>","PeriodicalId":6889,"journal":{"name":"Acta medica Indonesiana","volume":"56 1","pages":"126-133"},"PeriodicalIF":1.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140334280","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Secondary Polycythemia and Non-Islet Cell Tumor-induced Hypoglycemia in Advanced Hepatocellular Carcinoma: A Case Report. 晚期肝细胞癌继发性多血症和非胰岛细胞肿瘤诱发的低血糖症:病例报告。
IF 1.4 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-01-01
Maria Satya Paramitha, Dekta Filantropi Esa, Ni Made Hustrini, Nadia Ayu Mulansari, Irsan Hasan, Agnes Stephanie Harahap

Continuously holding its position as the sixth most common cause of cancer and the third leading cause of cancer death, globally, Hepatocellular Carcinoma (HCC) remains as a healthcare priority. Production of various substances may result into systemic or metabolic complications, often known as paraneoplastic phenomena of HCC. A 56-year-old male with history of untreated chronic hepatitis B arrived with generalized weakness and intermittent headache in the last two days prior to admission. Laboratory findings demonstrated elevated hemoglobin (20.5 g/dl), alpha-fetoprotein (29,845 ng/dl), and d-Dimer (2,120 ng/ml) levels. Hypoglycemia (44 mg/dl) was documented with normal basal insulin level, confirming non-islet cell tumor hypoglycemia. Abdominal multiphasic CT-scan demonstrated a large solid lesion involving the whole right liver lobe, hyper-enhanced at arterial phase and wash-out pattern at venous and delayed phases, with portal vein thrombosis; thus, confirming HCC BCLC C. Further examinations revealed hypercellularity from bone marrow biopsy with the absence of JAK2 mutation. He underwent serial phlebotomy and received 80 mg acetylsalicylic acid orally, as well as cytoreductive agent to reduce the risk of thrombosis. Despite applications of different interventions, control of hypoglycemia could not be achieved without parenteral administration of high dextrose load. He was planned to receive oral multikinase inhibitor, however, he passed away due to severe hospital-acquired pneumonia. Paraneoplastic phenomena are common in HCC. Increased risk of blood hyper-viscosity and thrombosis attributed to polycythemia, as well as medical emergency resulting from hypoglycemia showed that both conditions should not be overlooked since they may worsen the patient's prognosis.

肝细胞癌(HCC)一直是全球第六大常见癌症和第三大癌症死因,也是医疗保健的重点。各种物质的产生可能导致全身或代谢并发症,通常被称为 HCC 的副肿瘤现象。一名 56 岁的男性患者曾患慢性乙型肝炎,未接受过治疗,入院前两天出现全身乏力和间歇性头痛。实验室检查结果显示血红蛋白(20.5 g/dl)、甲胎蛋白(29845 ng/dl)和 d-二聚体(2120 ng/ml)水平升高。患者出现低血糖(44 毫克/分升),但基础胰岛素水平正常,这证实了非胰岛细胞肿瘤性低血糖症。腹部多相 CT 扫描显示,整个右肝叶有一个巨大的实性病变,动脉期高增强,静脉期和延迟期呈冲淡模式,伴有门静脉血栓形成;因此,确定为 HCC BCLC C。他接受了连续抽血检查,并口服了80毫克乙酰水杨酸和细胞溶解剂,以降低血栓形成的风险。尽管采取了各种干预措施,但如果不在肠外注射高浓度葡萄糖,就无法控制低血糖。他原计划接受口服多激酶抑制剂治疗,但却因严重的医院获得性肺炎而去世。副肿瘤现象在 HCC 中很常见。多血细胞症导致血液高粘度和血栓形成的风险增加,以及低血糖导致的医疗紧急情况表明,这两种情况都不容忽视,因为它们可能会恶化患者的预后。
{"title":"Secondary Polycythemia and Non-Islet Cell Tumor-induced Hypoglycemia in Advanced Hepatocellular Carcinoma: A Case Report.","authors":"Maria Satya Paramitha, Dekta Filantropi Esa, Ni Made Hustrini, Nadia Ayu Mulansari, Irsan Hasan, Agnes Stephanie Harahap","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Continuously holding its position as the sixth most common cause of cancer and the third leading cause of cancer death, globally, Hepatocellular Carcinoma (HCC) remains as a healthcare priority. Production of various substances may result into systemic or metabolic complications, often known as paraneoplastic phenomena of HCC. A 56-year-old male with history of untreated chronic hepatitis B arrived with generalized weakness and intermittent headache in the last two days prior to admission. Laboratory findings demonstrated elevated hemoglobin (20.5 g/dl), alpha-fetoprotein (29,845 ng/dl), and d-Dimer (2,120 ng/ml) levels. Hypoglycemia (44 mg/dl) was documented with normal basal insulin level, confirming non-islet cell tumor hypoglycemia. Abdominal multiphasic CT-scan demonstrated a large solid lesion involving the whole right liver lobe, hyper-enhanced at arterial phase and wash-out pattern at venous and delayed phases, with portal vein thrombosis; thus, confirming HCC BCLC C. Further examinations revealed hypercellularity from bone marrow biopsy with the absence of JAK2 mutation. He underwent serial phlebotomy and received 80 mg acetylsalicylic acid orally, as well as cytoreductive agent to reduce the risk of thrombosis. Despite applications of different interventions, control of hypoglycemia could not be achieved without parenteral administration of high dextrose load. He was planned to receive oral multikinase inhibitor, however, he passed away due to severe hospital-acquired pneumonia. Paraneoplastic phenomena are common in HCC. Increased risk of blood hyper-viscosity and thrombosis attributed to polycythemia, as well as medical emergency resulting from hypoglycemia showed that both conditions should not be overlooked since they may worsen the patient's prognosis.</p>","PeriodicalId":6889,"journal":{"name":"Acta medica Indonesiana","volume":"56 1","pages":"93-101"},"PeriodicalIF":1.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140334256","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Impact on Working Conditions and Income Amongst Internists in Indonesia: Lesson Learned from the COVID-19 Pandemic. 对印度尼西亚内科医生工作条件和收入的影响:从 COVID-19 大流行中汲取的教训。
IF 1.4 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-01-01
Sally Aman Nasution, Lugyanti Sukrisman, Simon Salim, Ni Made Hustrini, Rudi Hidayat, Evy Yunihastuti, Ceva W Pitoyo, Andhika Rachman, Sayang Rahmadini, Ginulur Gensyaf Adgani, Nurul Inayah Rahmani

Internists are at the forefront of providing care for COVID-19 patients. This situation adds more strain on already overburdened internists, particularly in Indonesia, where resources are scarce and unevenly distributed. The pandemic altered working conditions due to restrictions and regulatory changes. Multiple evidence exists for the effect of the COVID-19 pandemic on physicians' well-being, but less is known about its impact on their work dynamics and livelihoods. This study provides some lessons learned during the COVID-19 pandemic regarding the changes in working conditions and earnings experienced by Indonesian internists. There were 3,115 and 1,772 participants in the first and second survey, respectively. After one year, the proportion of internists handling COVID-19 cases, including critical COVID-19 cases, increased; with fewer internists over 60 years old involved. Working hours, number of patients, and monthly earnings decreased for the majority of internists. The increased workload was experienced by most participants one year of the pandemic, predominantly reported by female internists. The COVID-19 pandemic caused a considerable impact on working conditions and income amongst internists in Indonesia. These findings may provide information to institutions in formulating strategies and tools to improve the working conditions and livelihoods of internists in Indonesia amidst the pandemic and potential public health emergencies in the future.

内科医生是为 COVID-19 患者提供医疗服务的最前沿。这种情况给本已不堪重负的内科医生增加了更多压力,尤其是在资源稀缺且分布不均的印度尼西亚。由于限制和法规的变化,大流行改变了工作条件。有多种证据表明 COVID-19 大流行对医生的福利产生了影响,但对其工作动态和生计的影响却知之甚少。本研究就印度尼西亚内科医生在 COVID-19 大流行期间所经历的工作条件和收入变化提供了一些经验教训。第一次和第二次调查分别有 3,115 人和 1,772 人参加。一年后,处理 COVID-19 病例(包括 COVID-19 重症病例)的内科医生比例增加;60 岁以上的内科医生人数减少。大多数内科医生的工作时间、病人数量和月收入都有所减少。大流行一年后,大多数参与者的工作量都有所增加,其中以女性内科医生居多。COVID-19 大流行对印度尼西亚内科医生的工作条件和收入造成了相当大的影响。这些研究结果可为相关机构提供信息,帮助其制定战略和工具,以改善印度尼西亚内科医生在大流行病和未来可能发生的公共卫生突发事件中的工作条件和生计。
{"title":"The Impact on Working Conditions and Income Amongst Internists in Indonesia: Lesson Learned from the COVID-19 Pandemic.","authors":"Sally Aman Nasution, Lugyanti Sukrisman, Simon Salim, Ni Made Hustrini, Rudi Hidayat, Evy Yunihastuti, Ceva W Pitoyo, Andhika Rachman, Sayang Rahmadini, Ginulur Gensyaf Adgani, Nurul Inayah Rahmani","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Internists are at the forefront of providing care for COVID-19 patients. This situation adds more strain on already overburdened internists, particularly in Indonesia, where resources are scarce and unevenly distributed. The pandemic altered working conditions due to restrictions and regulatory changes. Multiple evidence exists for the effect of the COVID-19 pandemic on physicians' well-being, but less is known about its impact on their work dynamics and livelihoods. This study provides some lessons learned during the COVID-19 pandemic regarding the changes in working conditions and earnings experienced by Indonesian internists. There were 3,115 and 1,772 participants in the first and second survey, respectively. After one year, the proportion of internists handling COVID-19 cases, including critical COVID-19 cases, increased; with fewer internists over 60 years old involved. Working hours, number of patients, and monthly earnings decreased for the majority of internists. The increased workload was experienced by most participants one year of the pandemic, predominantly reported by female internists. The COVID-19 pandemic caused a considerable impact on working conditions and income amongst internists in Indonesia. These findings may provide information to institutions in formulating strategies and tools to improve the working conditions and livelihoods of internists in Indonesia amidst the pandemic and potential public health emergencies in the future.</p>","PeriodicalId":6889,"journal":{"name":"Acta medica Indonesiana","volume":"56 1","pages":"116-125"},"PeriodicalIF":1.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140334259","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Life-Threatening Complication During the Fourth Pregnancy Due to Acute Promyelocytic Leukemia: A Case Report. 急性早幼粒细胞白血病导致第四次妊娠并发危及生命的并发症:病例报告。
IF 1.4 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-01-01
Ismy Azizah Sisnawati, Kezia Salay, Listiana Nur Fadillah, Indi Jazilah, Jessica Amelinda Mintarjo, Atiyatum Billah, Agung Sunarko Putra, I Dewa Made Widi Hersana, Citra Novita

Incidents of leukemia in pregnancy are infrequent with only one case found from 75,000 to 100,000 pregnancies. The pathophysiological mechanism of leukemia during pregnancy is still unclear. Leukemia which occurs in pregnancy is usually acute and predominantly the myeloid type.A 35-year-old woman in her fourth pregnancy with a gestational age of 38-39 weeks, came to the emergency department (ED) with complaints of contractions since 4.5 hours before admission. The contraction was not accompanied by discharge, mucus, or blood, and fetal movements was still active. She denied complaints of fever, nausea, vomiting, dizziness, shortness of breath, weakness, fatigue, lethargy, and bleeding. Physical examination results, both palpebral conjunctiva were pale. Laboratory examination results of a complete blood count, white blood cell count were 2,930/uL, hemoglobin 8.3 g/dL, Hct 24.10%, erythrocytes 2.78x106/µL, platelets 62,000/µL. Bone Marrow Aspiration (BMA) revealed Acute Promyelocytic Leukemia (APL).APL is a subtype of Acute Myelogenous Leukemia (AML). Persistent fatigue, recurrent infections, and bleeding are common manifestations of APL. The diagnosis of APL is made by bone marrow aspiration examination, and it is safe for pregnancy. APL therapy in pregnancy uses All-Trans Retinoic Acid (ATRA) and Arsenic Trioxide (ATO). ATRA and ATO are highly teratogenic, but recent studies have reported no fetal abnormalities.Accuracy and speed in diagnosing and initiating APL therapy in pregnancy are essential in preventing serious complications.

妊娠期白血病并不常见,在 75 000 至 100 000 例妊娠中仅发现一例。妊娠期白血病的病理生理机制尚不清楚。一名 35 岁的妇女第四次怀孕,孕周为 38-39 周,因入院前 4.5 小时出现宫缩而到急诊科就诊。宫缩没有伴有分泌物、粘液或血液,胎动仍然活跃。她否认有发烧、恶心、呕吐、头晕、气短、虚弱、疲劳、嗜睡和出血等症状。体格检查结果显示,双侧睑结膜苍白。实验室检查结果为:全血细胞计数、白细胞计数 2 930/uL、血红蛋白 8.3 g/dL、Hct 24.10%、红细胞 2.78x106/μL、血小板 62 000/μL。骨髓抽吸术(BMA)显示为急性早幼粒细胞白血病(APL)。持续疲劳、反复感染和出血是 APL 的常见表现。APL 的诊断是通过骨髓穿刺检查做出的,对妊娠是安全的。妊娠期 APL 治疗使用全反式维甲酸(ATRA)和三氧化二砷(ATO)。全反式维甲酸和三氧化二砷具有很高的致畸性,但最近的研究没有发现胎儿畸形的报道。在妊娠期诊断和启动 APL 治疗的准确性和速度对于预防严重并发症至关重要。
{"title":"A Life-Threatening Complication During the Fourth Pregnancy Due to Acute Promyelocytic Leukemia: A Case Report.","authors":"Ismy Azizah Sisnawati, Kezia Salay, Listiana Nur Fadillah, Indi Jazilah, Jessica Amelinda Mintarjo, Atiyatum Billah, Agung Sunarko Putra, I Dewa Made Widi Hersana, Citra Novita","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Incidents of leukemia in pregnancy are infrequent with only one case found from 75,000 to 100,000 pregnancies. The pathophysiological mechanism of leukemia during pregnancy is still unclear. Leukemia which occurs in pregnancy is usually acute and predominantly the myeloid type.A 35-year-old woman in her fourth pregnancy with a gestational age of 38-39 weeks, came to the emergency department (ED) with complaints of contractions since 4.5 hours before admission. The contraction was not accompanied by discharge, mucus, or blood, and fetal movements was still active. She denied complaints of fever, nausea, vomiting, dizziness, shortness of breath, weakness, fatigue, lethargy, and bleeding. Physical examination results, both palpebral conjunctiva were pale. Laboratory examination results of a complete blood count, white blood cell count were 2,930/uL, hemoglobin 8.3 g/dL, Hct 24.10%, erythrocytes 2.78x106/µL, platelets 62,000/µL. Bone Marrow Aspiration (BMA) revealed Acute Promyelocytic Leukemia (APL).APL is a subtype of Acute Myelogenous Leukemia (AML). Persistent fatigue, recurrent infections, and bleeding are common manifestations of APL. The diagnosis of APL is made by bone marrow aspiration examination, and it is safe for pregnancy. APL therapy in pregnancy uses All-Trans Retinoic Acid (ATRA) and Arsenic Trioxide (ATO). ATRA and ATO are highly teratogenic, but recent studies have reported no fetal abnormalities.Accuracy and speed in diagnosing and initiating APL therapy in pregnancy are essential in preventing serious complications.</p>","PeriodicalId":6889,"journal":{"name":"Acta medica Indonesiana","volume":"56 1","pages":"76-83"},"PeriodicalIF":1.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140334278","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness and Safety of Nebulized Magnesium as Last Line Treatment in Adults with Acute Asthma Attack: A Systematic Review and Meta-Analysis. 雾化镁作为成人哮喘急性发作最后一线治疗的有效性和安全性:系统回顾与元分析》。
IF 0.7 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-01-01
Danny Darmawan, Iris Rengganis, Cleopas Martin Rumende, Hamzah Shatri, Soekamto Koesnoe, Yogi Umbarawan, Rudi Putranto, Sally Aman Nasution

Background: Asthma is a disease characterized by chronic airway inflammation, however one-third of asthmatic cases did not respond adequately. Inhaled magnesium has been proposed as a treatment for unresponsive asthma cases. However, its role remains controversial. This review evaluates the effectiveness and safety of nebulized magnesium compared to standard therapy (Beta Agonist, Anticholinergic, Corticosteroid) in adults with acute asthma attacks.

Methods: The protocol has been registered in PROSPERO. A literature search was conducted through PubMed/MEDLINE, Cochrane, ProQuest, and Google Scholar, and using the keywords "inhaled magnesium" and "asthma". Manual searches were carried out through data portals. Journal articles included are randomized controlled trials. The assessment risk of bias was performed using Version 2 of the Cochrane risk-of-bias tool for randomized trials.

Results: There are five articles included in this review. There is no significant difference in readmission rate and oxygen saturation in the magnesium group compared to control (RR 1; 95% CI 0.92 to 1,08; p= 0,96 and MD 1,82; 95% CI -0.89 to 4.53; p= 0.19, respectively). There is a significant reduction of respiratory rate and clinical severity in magnesium (MD -1,72; 95% CI -3,1 to 0.35; p= 0.01, RR 0.29; 95% CI 0.17 to 0.69; p <0.001, respectively). There was a higher risk of side effects in the magnesium group (HR 1.56; 95%CI 1.05 to 2.32; p= 0.03). However, the side effects are relatively mild such as hypotension and nausea.

Conclusion: Inhaled magnesium improves the outcome of asthmatic patients, especially in lung function, clinical severity, and respiratory rate. Moreover, inhaled magnesium is safe to be given.

背景:哮喘是一种以慢性气道炎症为特征的疾病:哮喘是一种以慢性气道炎症为特征的疾病,但三分之一的哮喘病例没有得到充分治疗。吸入镁被认为是治疗无反应哮喘的一种方法。然而,其作用仍存在争议。本综述评估了雾化吸入镁与标准疗法(β-受体激动剂、抗胆碱能药、皮质类固醇)相比,在成人哮喘急性发作中的有效性和安全性:该方案已在 PROSPERO 注册。文献检索通过 PubMed/MEDLINE、Cochrane、ProQuest 和 Google Scholar 进行,关键词为 "吸入镁 "和 "哮喘"。还通过数据门户网站进行了人工搜索。收录的期刊文章均为随机对照试验。使用科克伦随机试验偏倚风险工具第 2 版对偏倚风险进行了评估:本综述共纳入五篇文章。与对照组相比,镁组的再入院率和血氧饱和度没有明显差异(分别为 RR 1; 95% CI 0.92 至 1,08; p= 0,96 和 MD 1,82; 95% CI -0.89 至 4.53; p= 0.19)。吸入镁剂可明显降低呼吸频率和临床严重程度(MD -1,72; 95% CI -3,1 to 0.35; p= 0.01,RR 0.29; 95% CI 0.17 to 0.69; p 结论:吸入镁剂可改善呼吸频率和临床严重程度:吸入镁能改善哮喘患者的预后,尤其是在肺功能、临床严重程度和呼吸频率方面。此外,吸入镁是安全的。
{"title":"Effectiveness and Safety of Nebulized Magnesium as Last Line Treatment in Adults with Acute Asthma Attack: A Systematic Review and Meta-Analysis.","authors":"Danny Darmawan, Iris Rengganis, Cleopas Martin Rumende, Hamzah Shatri, Soekamto Koesnoe, Yogi Umbarawan, Rudi Putranto, Sally Aman Nasution","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Asthma is a disease characterized by chronic airway inflammation, however one-third of asthmatic cases did not respond adequately. Inhaled magnesium has been proposed as a treatment for unresponsive asthma cases. However, its role remains controversial. This review evaluates the effectiveness and safety of nebulized magnesium compared to standard therapy (Beta Agonist, Anticholinergic, Corticosteroid) in adults with acute asthma attacks.</p><p><strong>Methods: </strong>The protocol has been registered in PROSPERO. A literature search was conducted through PubMed/MEDLINE, Cochrane, ProQuest, and Google Scholar, and using the keywords \"inhaled magnesium\" and \"asthma\". Manual searches were carried out through data portals. Journal articles included are randomized controlled trials. The assessment risk of bias was performed using Version 2 of the Cochrane risk-of-bias tool for randomized trials.</p><p><strong>Results: </strong>There are five articles included in this review. There is no significant difference in readmission rate and oxygen saturation in the magnesium group compared to control (RR 1; 95% CI 0.92 to 1,08; p= 0,96 and MD 1,82; 95% CI -0.89 to 4.53; p= 0.19, respectively). There is a significant reduction of respiratory rate and clinical severity in magnesium (MD -1,72; 95% CI -3,1 to 0.35; p= 0.01, RR 0.29; 95% CI 0.17 to 0.69; p <0.001, respectively). There was a higher risk of side effects in the magnesium group (HR 1.56; 95%CI 1.05 to 2.32; p= 0.03). However, the side effects are relatively mild such as hypotension and nausea.</p><p><strong>Conclusion: </strong>Inhaled magnesium improves the outcome of asthmatic patients, especially in lung function, clinical severity, and respiratory rate. Moreover, inhaled magnesium is safe to be given.</p>","PeriodicalId":6889,"journal":{"name":"Acta medica Indonesiana","volume":"56 1","pages":"3-12"},"PeriodicalIF":0.7,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140334281","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Acta medica Indonesiana
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1